US Broker Ratings

LivaNova PLC (LIVN) Stock Analysis: Navigating Market Growth with a 13.71% Potential Upside

LivaNova PLC (LIVN), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with its solid performance and promising future outlook. With a..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring the 17% Potential Upside for Investors

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Switzerland-based biotechnology company, has captured investor attention with its ambitious focus on developing innovative therapies for inflammatory skin and joint diseases. The company’s leading candidate,..

Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Leader with 17.49% Potential Upside

Veracyte, Inc. (VCYT), a leading player in the healthcare sector, stands out in the diagnostics and research industry with its innovative genomic tests. Headquartered in South San Francisco, Veracyte is..

AdaptHealth Corp. (AHCO) Stock Analysis: A 30% Upside Potential in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector should take a closer look at AdaptHealth Corp. (NASDAQ: AHCO), a promising player in the medical devices industry with a market capitalization of..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring the Potential of Synthetic DNA and a Strong Buy Consensus

Investors with an eye on the healthcare sector might find Twist Bioscience Corporation (NASDAQ: TWST) an intriguing prospect. Positioned at the forefront of synthetic DNA manufacturing, Twist Bioscience boasts a..

Innoviva, Inc. (INVA): Investor Outlook Highlights 66.5% Potential Upside

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, offers intriguing prospects for investors seeking exposure in the healthcare industry. Headquartered in Burlingame, California, Innoviva is primarily engaged..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Assessing the 6.27% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD) operates within the healthcare sector, specifically focusing on medical care facilities in the United States. With a market capitalization of $1.86 billion, the company..

Ascentage Pharma Group Internat (AAPG): Investor Outlook on a Biotech Pioneer with 78.64% Potential Upside

Ascentage Pharma Group Internat (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is carving a significant niche in the healthcare sector with its innovative therapies targeting cancers, chronic hepatitis..

Artivion, Inc. (AORT) Stock Analysis: A 20% Upside Potential in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the medical devices industry, has been capturing the attention of investors with its significant upside potential, driven by innovative products and strategic..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 9% Potential Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may want to take a closer look at Azenta, Inc. (NASDAQ: AZTA), a company that specializes in providing innovative solutions for biological..

SS Innovations International (SSII) Stock Analysis: Navigating the Robotic Revolution with 192.5% Revenue Growth

Investors looking for exposure in the burgeoning field of surgical robotics should pay close attention to SS Innovations International, Inc. (SSII). Headquartered in Gurugram, India, this healthcare company is making..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 52.51% Potential Upside in Biotech

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) presents an intriguing opportunity for investors looking to delve into the biotechnology sector. This clinical-stage company, headquartered in Salt Lake City, Utah, is pioneering the..

ICU Medical, Inc. (ICUI) Stock Analysis: A Potential 18.3% Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI) presents a compelling investment case for those eyeing the healthcare sector, particularly in the medical instruments and supplies industry. As a United States-based company with..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Uncovering a 53.98% Potential Upside in Biotech

Investors keen on the biotechnology sector should take a closer look at Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising player in the healthcare industry. With a market capitalization of $2.61..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 29.85% Potential Upside in Healthcare Plans

Clover Health Investments, Corp (NASDAQ: CLOV), a prominent player in the healthcare plans sector, offers a unique investment opportunity, especially for those seeking exposure to the burgeoning Medicare Advantage market...

BioLife Solutions, Inc. (BLFS): Investor Outlook Highlights 30% Potential Upside with Strong Buy Ratings

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers a compelling investment opportunity for those interested in the..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Unveiling a 14% Upside Potential in Healthcare

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the medical care facilities industry with a market capitalization of $1.94 billion, has caught the attention of investors with its..

10x Genomics, Inc. (TXG) Stock Analysis: A Cautious Investor Outlook Amidst Negative Revenue Growth

10x Genomics, Inc. (TXG) is a prominent player in the healthcare sector, specifically within the Health Information Services industry. Headquartered in Pleasanton, California, the company has carved a niche in..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Biotechnology Innovator with 122% Upside Potential

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing investor attention thanks to its innovative approach in the biotechnology sector and a remarkable potential upside of 122.68%. As a biopharmaceutical company based..

HUTCHMED (China) Limited (HCM) Stock Analysis: Uncovering a 35.50% Potential Upside Amid Mixed Financial Signals

HUTCHMED (China) Limited, trading under the ticker symbol HCM, stands as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Hong..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds